Alpha Interferon

Overview Forums Topics Doctor Questions eHealthpedia
Ask our Community
Members
eHealthpedia Articles
Hepatitis Treatment
Hepatitis disease progression can be very serious. Learn how doctors treat different types of hepatitis, and how to protect yourself against infection.
Chronic Fatigue Diagnosis
Doctors don't agree how to diagnose chronic fatigue. Start here for info about CFS-sensitive doctors and which tests and exams to expect during an office visit.
More
Topics
Ataxia
Ataxia / Brain and Head Injuries
Ataxia
Ataxia / Brain and Head Injuries
KingHassani
KingHassani / Liver Disorders, Hepatitis A,B,C
hash444
hash444 / Liver Disorders, Hepatitis A,B,C
2occhi
2occhi / Liver Disorders, Hepatitis A,B,C
More
Doctor Answers
Dr. Nikola Gjuzelov
Dr. Nikola Gjuzelov / Sexual Health - Men
More
News
Press Release
La Merie's report provides a competitor evaluation in the field of specifically targeted antiviral therapeutics for hepatitis C (STAT-C) as of August 2011. Purchase of the downloadable pdf report includes 6-month online access to the data of the report an
Compass Biotechnologies, Inc. Seeking Drugs to Fight and Prevent HCV Infection
CompassBiotech Making Drugs to Combat Major Human Diseases EDMONTON, Sept. 26, 2011 /PRNewswire/ - Compass (COBI:OB) is pleased to announce new research findings that it believes will alter the course of HCV vaccine development and other vaccines in gener
Peregrine Completes Patient Enrollment in Randomized Phase II HCV Trial for Bavituximab
HCV Trial Evaluating 12 Weeks of Therapy With Bavituximab With Ribavirin; Early Virologic Response (EVR) Data Expected by End of 2011 or Early 2012
Compass Announces Expanded Relationship With PanGen Biotech and Enters $13 Billion Global Laboratory Reagents Market
CompassBiotech Making prescription drugs affordable EDMONTON, Sept. 27, 2011 /PRNewswire/ - Compass Biotechnologies (COBI:OB) is a product-oriented specialty biotechnology company focused on offering products for multi-billion dollar markets.  The compan
Cytokines and Growth Factors to be first Laboratory Reagents Marketed and Sold by Compass Biotechnologies Inc
Making prescription drugs affordable EDMONTON, Sept. 28, 2011 /PRNewswire/ - Compass Biotechnologies, Inc. (COBI: OB) prepares to market, sell and distribute recombinant human cytokines and growth factors for research purposes. Further to the recent annou